On the other hand, a potential anti-tumoral effect of IGFBP3 was proposed by Belizon et al., in light of evidence of an increased rate of colon cancer in mice with low IGFBP3 [129]. This evidence concerns the gene IGFBP3 and colonic neoplasm.